Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus

被引：0
作者：
A K Hemanth Kumar
V Chandrasekaran
T Kannan
A Lakshmi Murali
J Lavanya
V Sudha
Soumya Swaminathan
Geetha Ramachandran
机构：
[1] National Institute for Research in Tuberculosis,Department of Biochemistry and Clinical Pharmacology
[2] State TB Officer,undefined
[3] District TB Officer,undefined
来源：
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词：
Tuberculosis; Anti-tuberculosis drug concentrations; Revised National Tuberculosis Control Programme; Diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 70
页数：5
相关论文
共 50 条
  • [1] Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus
    Kumar, A. K. Hemanth
    Chandrasekaran, V.
    Kannan, T.
    Murali, A. Lakshmi
    Lavanya, J.
    Sudha, V.
    Swaminathan, Soumya
    Ramachandran, Geetha
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (01) : 65 - 70
  • [2] A novel risk factor for predicting anti-tuberculosis drug resistance in patients with tuberculosis complicated with type 2 diabetes mellitus
    Lyu, Mengyuan
    Wang, Dongmei
    Zhao, Junwei
    Yang, Zengwei
    Chong, Weelic
    Zhao, Zhenzhen
    Ming, Liang
    Ying, Binwu
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 97 : 69 - 77
  • [3] Anti-tuberculosis drug concentrations and treatment outcomes among HIV-infected patients with tuberculosis
    Baniasadi, Shadi
    Alehashem, Maryam
    Kobarfard, Farzad
    Tabarsi, Payam
    HIV & AIDS REVIEW, 2018, 17 (02): : 111 - 116
  • [4] Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India
    Swaminathan, S
    Paramasivan, CN
    Ponnuraja, C
    Iliayas, S
    Rajasekaran, S
    Narayanan, RR
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (08) : 896 - 900
  • [5] Bidirectional Screening of Tuberculosis Patients for Diabetes Mellitus and Diabetes Patients for Tuberculosis
    Jali, Mallikarjun V.
    Mahishale, Vinay K.
    Hiremath, Murigendra B.
    DIABETES & METABOLISM JOURNAL, 2013, 37 (04) : 291 - 295
  • [6] Evaluation of Systemic Inflammation Before and After Standard Anti-tuberculosis Treatment in Patients With Active Pulmonary Tuberculosis and Diabetes Mellitus
    Lopez-Gonzalez, Jesus Andres
    Martinez-Soto, Juan Manuel
    Avila-Cervantes, Carolina
    Mata-Pineda, Ana Lourdes
    Alvarez-Hernandez, Gerardo
    Alvarez-Meza, Jehan Bonizu
    Bolado-Martinez, Enrique
    Candia-Plata, Maria del Carmen
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [7] Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus
    Ichikawa, Chikako
    Tanaka, Sho
    Takubo, Masahiro
    Kushimoto, Masaru
    Ikeda, Jin
    Ogawa, Katsuhiko
    Tsujino, Ichiro
    Suzuki, Yutaka
    Abe, Masanori
    Ishihara, Hisamitsu
    Fujishiro, Midori
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 463 - 470
  • [8] Anti-tuberculosis drug resistance in Portugal
    Antunes, ML
    Aleixo-Dias, J
    Antunes, AF
    Pereira, MF
    Raymundo, E
    Rodrigues, MF
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2000, 4 (03) : 223 - 231
  • [9] Plan of Anti-tuberculosis Treatment in Patients with Abdominal Tuberculosis
    Mohanty, Debajyoti
    Halder, Anindya
    Srivastava, Niraj
    INDIAN JOURNAL OF SURGERY, 2016, 78 (02) : 166 - 167
  • [10] Plan of Anti-tuberculosis Treatment in Patients with Abdominal Tuberculosis
    Debajyoti Mohanty
    Anindya Halder
    Niraj Srivastava
    Indian Journal of Surgery, 2016, 78 : 166 - 167
12345